FILING ANALYSIS · THURSDAY, NOVEMBER 12
Cibus, Inc. CBUS — 8-K: Results of Operations and Financial Condition
neutral
Cibus reported a 19% year-over-year decrease in cash used in operating activities and initiated the manufacturing process for its initial two biofragrance products, which could represent a $100 million peak annual revenue opportunity. The company's Rice traits performed well in Latin American field trials and are being tested by customer Interoc in its own varieties.
How we read impact: we grade every directional call in the open. Impact labels are AI estimates — not investment advice. See the full disclaimer.
Get filings like this every market day
The US SEC filings, UK RNS, EU notices, and Polymarket odds that matter — scored by AI, in one email.
Subscribe free →